CRYOPORT, INC. Operating Income
CRYOPORT, INC. (CYRX) reported Operating Income of -$10.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- CRYOPORT, INC. operating income (loss) for the quarter ending 2026-06-30 was -$10.04M.
- CRYOPORT, INC. operating income (loss) for the quarter ending 2026-03-31 was -$9.61M.
- CRYOPORT, INC. operating income (loss) for the quarter ending 2025-12-31 was -$10.03M.
- CRYOPORT, INC. operating income (loss) for the quarter ending 2025-09-30 was -$9.93M.
- CRYOPORT, INC. operating income (loss) for fiscal 2025 was -$36.81M.
- CRYOPORT, INC. operating income (loss) for fiscal 2024 was -$121.67M.
- CRYOPORT, INC. operating income (loss) for fiscal 2023 was -$100.54M.
- CRYOPORT, INC. operating income (loss) for fiscal 2022 was -$31.90M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.04M 10-Q · filed 2026-08-06 | -$19.65M 10-Q · filed 2026-08-06 | -$29.68M derived: sum of 3 quarters · filed 2026-08-06 | -$39.62M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$9.61M 10-Q · filed 2026-05-05 | -$19.64M derived: sum of 2 quarters · filed 2026-05-05 | -$29.58M derived: sum of 3 quarters · filed 2026-05-05 | -$39.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$19.96M derived: sum of 2 quarters · filed 2026-03-05 | -$29.61M derived: sum of 3 quarters · filed 2026-08-06 | -$36.81M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$9.93M 10-Q · filed 2025-11-06 | -$19.58M derived: sum of 2 quarters · filed 2026-08-06 | -$26.77M 10-Q · filed 2025-11-06 | -$39.52M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$9.65M 10-Q · filed 2026-08-06 | -$16.84M 10-Q · filed 2026-08-06 | -$29.59M derived: sum of 3 quarters · filed 2026-08-06 | -$42.98M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$7.19M 10-Q · filed 2026-05-05 | -$9.48M 10-Q · filed 2025-05-08 | -$19.94M derived: sum of 2 quarters · filed 2026-05-05 | -$33.33M derived: sum of 3 quarters · filed 2026-05-05 | -$111.36M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | -$12.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$26.13M derived: sum of 2 quarters · filed 2026-03-05 | -$104.16M derived: sum of 3 quarters · filed 2026-03-05 | -$121.67M 10-K · filed 2026-03-05 | -$130.87M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | -$13.39M 10-Q · filed 2025-11-06 | -$16.43M 10-Q · filed 2024-11-07 | -$91.42M derived: sum of 2 quarters · filed 2025-11-06 | -$108.93M 10-Q · filed 2025-11-06 | -$116.94M 10-Q · filed 2024-11-07 | -$164.18M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-06-30 | -$78.03M 10-Q · filed 2025-08-12 | -$79.23M 10-Q · filed 2024-08-08 | -$95.54M 10-Q · filed 2025-08-12 | -$100.51M 10-Q · filed 2024-08-08 | -$150.79M derived: sum of 3 quarters · filed 2026-03-05 | -$167.70M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-03-31 | -$17.51M 10-Q · filed 2025-05-08 | -$21.28M 10-Q · filed 2024-05-08 | -$72.76M derived: sum of 2 quarters · filed 2026-03-05 | -$89.67M derived: sum of 3 quarters · filed 2026-03-05 | -$108.00M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2023-12-31 | -$55.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$72.16M derived: sum of 2 quarters · filed 2026-03-05 | -$90.49M derived: sum of 3 quarters · filed 2026-03-05 | -$100.54M 10-K · filed 2026-03-05 | -$115.16M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | -$16.91M 10-Q · filed 2024-11-07 | -$35.24M derived: sum of 2 quarters · filed 2024-11-07 | -$45.29M 10-Q · filed 2024-11-07 | -$56.32M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$18.33M 10-Q · filed 2024-08-08 | -$28.38M 10-Q · filed 2024-08-08 | -$39.41M derived: sum of 3 quarters · filed 2024-08-08 | -$47.22M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$10.04M 10-Q · filed 2024-05-08 | -$21.08M derived: sum of 2 quarters · filed 2024-05-08 | -$28.88M derived: sum of 3 quarters · filed 2024-05-08 | -$34.13M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$11.04M 10-K · filed 2023-02-28 | -$18.84M derived: sum of 2 quarters · filed 2023-11-09 | -$24.09M derived: sum of 3 quarters · filed 2023-11-09 | -$31.90M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | -$7.80M 10-Q · filed 2023-11-09 | -$13.05M derived: sum of 2 quarters · filed 2023-11-09 | -$20.87M 10-Q · filed 2023-11-09 | -$29.23M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$5.25M 10-Q · filed 2023-08-09 | -$13.07M 10-Q · filed 2023-08-09 | -$21.43M derived: sum of 3 quarters · filed 2023-08-09 | -$26.00M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$7.82M 10-Q · filed 2023-05-04 | -$16.18M derived: sum of 2 quarters · filed 2023-05-04 | -$20.76M derived: sum of 3 quarters · filed 2023-05-04 | -$24.50M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$8.36M 10-K · filed 2023-02-28 | -$12.94M derived: sum of 2 quarters · filed 2023-02-28 | -$16.69M derived: sum of 3 quarters · filed 2023-02-28 | -$17.83M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | -$4.58M 10-K · filed 2023-02-28 | -$8.32M derived: sum of 2 quarters · filed 2023-02-28 | -$9.47M 10-Q · filed 2022-11-04 | -$19.31M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$3.75M 10-K · filed 2023-02-28 | -$4.89M 10-Q · filed 2022-08-04 | -$14.74M derived: sum of 3 quarters · filed 2023-02-28 | -$25.47M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$1.14M 10-K · filed 2023-02-28 | -$10.99M derived: sum of 2 quarters · filed 2023-02-28 | -$21.72M derived: sum of 3 quarters · filed 2023-02-28 | -$27.57M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$9.85M 10-K · filed 2023-02-28 | -$20.58M derived: sum of 2 quarters · filed 2023-02-28 | -$26.42M derived: sum of 3 quarters · filed 2023-02-28 | -$30.01M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$10.73M 10-K · filed 2023-02-28 | -$10.73M 10-Q · filed 2020-11-06 | -$16.58M derived: sum of 2 quarters · filed 2023-02-28 | -$20.16M 10-Q · filed 2021-11-04 | -$20.16M 10-Q · filed 2020-11-06 | -$21.04M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-06-30 | -$5.84M 10-K · filed 2023-02-28 | -$5.85M 10-Q · filed 2020-08-10 | -$9.43M 10-Q · filed 2021-08-06 | -$9.43M 10-Q · filed 2020-08-10 | -$10.31M derived: sum of 3 quarters · filed 2023-02-28 | -$22.66M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-03-31 | -$3.59M 10-K · filed 2023-02-28 | -$3.59M 10-Q · filed 2020-05-08 | -$4.46M derived: sum of 2 quarters · filed 2023-02-28 | -$16.82M derived: sum of 3 quarters · filed 2023-02-28 | -$19.12M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2019-12-31 | -$878.00K 10-K · filed 2022-02-28 | -$13.23M derived: sum of 2 quarters · filed 2022-02-28 | -$15.53M derived: sum of 3 quarters · filed 2022-02-28 | -$17.68M 10-K · filed 2022-02-28 | -$17.68M 10-K · filed 2020-03-10 | |||
| 2019-09-30 | -$12.35M 10-K · filed 2022-02-28 | -$12.35M 10-Q · filed 2019-11-12 | -$14.66M derived: sum of 2 quarters · filed 2022-02-28 | -$16.80M 10-Q · filed 2020-11-06 | -$19.02M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-06-30 | -$2.30M 10-K · filed 2022-02-28 | -$2.30M 10-Q · filed 2019-08-09 | -$4.44M 10-Q · filed 2020-08-10 | -$6.67M derived: sum of 3 quarters · filed 2022-02-28 | -$8.83M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-03-31 | -$2.14M 10-K · filed 2022-02-28 | -$2.14M 10-Q · filed 2019-05-09 | -$4.36M derived: sum of 2 quarters · filed 2022-02-28 | -$6.52M derived: sum of 3 quarters · filed 2022-02-28 | -$8.99M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2018-12-31 | -$2.22M 10-K · filed 2020-03-10 | -$4.38M derived: sum of 2 quarters · filed 2020-03-10 | -$6.85M derived: sum of 3 quarters · filed 2020-03-10 | -$8.64M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | -$2.16M 10-K · filed 2020-03-10 | -$2.16M 10-Q · filed 2018-11-08 | -$4.63M derived: sum of 2 quarters · filed 2020-03-10 | -$6.42M 10-Q · filed 2019-11-12 | -$8.70M derived: sum of 4 quarters · filed 2020-03-10 | |||
| 2018-06-30 | -$2.46M 10-K · filed 2020-03-10 | -$2.47M 10-Q · filed 2018-08-09 | -$4.26M 10-Q · filed 2019-08-09 | -$6.53M derived: sum of 3 quarters · filed 2020-03-10 | -$8.52M derived: sum of 4 quarters · filed 2020-03-10 | |||
| 2018-03-31 | -$1.80M 10-K · filed 2020-03-10 | -$1.80M 10-Q · filed 2018-05-03 | -$4.07M derived: sum of 2 quarters · filed 2020-03-10 | -$6.06M derived: sum of 3 quarters · filed 2020-03-10 | -$7.92M derived: sum of 4 quarters · filed 2020-03-10 | |||
| 2017-12-31 | -$2.27M 10-K · filed 2019-03-13 | -$4.26M derived: sum of 2 quarters · filed 2019-03-13 | -$6.12M derived: sum of 3 quarters · filed 2019-03-13 | -$7.89M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$1.99M 10-K · filed 2019-03-13 | -$1.99M 10-Q · filed 2017-11-02 | -$3.85M derived: sum of 2 quarters · filed 2019-03-13 | -$5.62M 10-Q · filed 2018-11-08 | -$7.62M derived: sum of 4 quarters · filed 2019-03-13 | |||
| 2017-06-30 | -$1.86M 10-K · filed 2019-03-13 | -$1.86M 10-Q · filed 2017-08-09 | -$3.63M 10-Q · filed 2018-08-09 | -$5.63M derived: sum of 3 quarters · filed 2019-03-13 | -$7.80M derived: sum of 4 quarters · filed 2019-03-13 | |||
| 2017-03-31 | -$1.77M 10-K · filed 2019-03-13 | -$1.77M 10-Q · filed 2017-05-04 | -$3.77M derived: sum of 2 quarters · filed 2019-03-13 | -$5.93M derived: sum of 3 quarters · filed 2019-03-13 | -$7.91M derived: sum of 4 quarters · filed 2019-03-13 | |||
| 2016-12-31 | -$2.00M 10-K · filed 2018-03-08 | -$4.16M derived: sum of 2 quarters · filed 2018-03-08 | -$6.14M 10-K · filed 2018-03-08 | -$8.77M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | -$2.16M 10-K · filed 2018-03-08 | -$2.16M 10-Q · filed 2016-11-14 | -$4.14M 10-Q · filed 2016-11-14 | -$6.76M 10-Q · filed 2017-11-02 | -$6.82M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-06-30 | -$1.98M 10-K · filed 2018-03-08 | -$1.98M 10-Q · filed 2016-08-15 | -$4.60M 10-Q · filed 2017-08-09 | -$4.66M derived: sum of 3 quarters · filed 2018-03-08 | -$6.48M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-03-31 | $0.00 10-K · filed 2018-03-08 | -$2.62M 10-K · filed 2016-06-28 | -$2.68M derived: sum of 2 quarters · filed 2018-03-08 | -$4.50M derived: sum of 3 quarters · filed 2018-03-08 | -$8.74M 10-KT · filed 2017-03-13 | |||
| 2015-12-31 | -$2.68M 10-KT · filed 2017-03-13 | -$2.68M 10-Q · filed 2016-02-11 | -$4.50M derived: sum of 2 quarters · filed 2017-03-13 | -$6.12M 10-KT · filed 2017-03-13 | -$8.74M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-09-30 | -$1.82M 10-KT · filed 2017-03-13 | -$1.82M 10-Q · filed 2015-11-16 | -$3.44M 10-Q · filed 2016-11-14 | -$6.06M derived: sum of 3 quarters · filed 2017-03-13 | -$7.42M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-06-30 | -$1.62M 10-KT · filed 2017-03-13 | -$1.62M 10-Q · filed 2015-08-06 | -$4.24M derived: sum of 2 quarters · filed 2017-03-13 | -$5.60M derived: sum of 3 quarters · filed 2017-03-13 | -$6.97M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-03-31 | -$2.62M 10-KT · filed 2017-03-13 | -$1.69M 10-K · filed 2015-05-19 | -$3.98M derived: sum of 2 quarters · filed 2017-03-13 | -$5.36M derived: sum of 3 quarters · filed 2017-03-13 | -$5.59M 10-K · filed 2016-06-28 | |||
| 2014-12-31 | -$1.36M 10-K · filed 2016-06-28 | -$1.36M 10-Q · filed 2015-02-05 | -$2.73M derived: sum of 2 quarters · filed 2016-06-28 | -$3.90M 10-Q · filed 2016-02-11 | -$5.17M derived: sum of 4 quarters · filed 2016-06-28 | |||
| 2014-09-30 | -$1.38M 10-K · filed 2016-06-28 | -$1.38M 10-Q · filed 2014-11-12 | -$2.54M 10-Q · filed 2015-11-16 | -$3.82M derived: sum of 3 quarters · filed 2016-06-28 | -$5.07M derived: sum of 4 quarters · filed 2016-06-28 | |||
| 2014-06-30 | -$1.17M 10-K · filed 2016-06-28 | -$1.17M 10-Q · filed 2014-07-31 | -$2.44M derived: sum of 2 quarters · filed 2016-06-28 | -$3.70M derived: sum of 3 quarters · filed 2016-06-28 | -$4.99M derived: sum of 4 quarters · filed 2016-06-28 | |||
| 2014-03-31 | -$1.27M 10-K · filed 2015-05-19 | -$2.53M derived: sum of 2 quarters · filed 2015-05-19 | -$3.82M derived: sum of 3 quarters · filed 2015-05-19 | -$5.08M 10-K · filed 2015-05-19 | ||||
| 2013-12-31 | -$1.26M 10-K · filed 2015-05-19 | -$1.26M 10-Q · filed 2014-02-13 | -$2.54M derived: sum of 2 quarters · filed 2015-05-19 | -$3.80M 10-Q · filed 2015-02-05 | -$5.49M derived: sum of 4 quarters · filed 2015-05-19 | |||
| 2013-09-30 | -$1.29M 10-K · filed 2015-05-19 | -$1.29M 10-Q · filed 2013-11-18 | -$2.55M 10-Q · filed 2014-11-12 | -$4.23M derived: sum of 3 quarters · filed 2015-05-19 | -$5.78M derived: sum of 4 quarters · filed 2015-05-19 | |||
| 2013-06-30 | -$1.26M 10-K · filed 2015-05-19 | -$1.26M 10-Q · filed 2013-08-14 | -$2.94M derived: sum of 2 quarters · filed 2015-05-19 | -$4.49M derived: sum of 3 quarters · filed 2015-05-19 | -$6.04M derived: sum of 4 quarters · filed 2015-05-19 | |||
| 2013-03-31 | -$1.68M 10-K · filed 2014-06-25 | -$1.68K 10-K · filed 2013-06-25 | -$3.23M derived: sum of 2 quarters · filed 2014-06-25 | -$4.78M derived: sum of 3 quarters · filed 2014-06-25 | -$6.32M 10-K · filed 2014-06-25 | |||
| 2012-12-31 | -$1.55M 10-K · filed 2014-06-25 | -$1.55M 10-Q · filed 2013-02-14 | -$3.10M derived: sum of 2 quarters · filed 2014-06-25 | -$4.64M 10-Q · filed 2014-02-13 | -$4.65M derived: sum of 4 quarters · filed 2014-06-25 | |||
| 2012-09-30 | -$1.55M 10-K · filed 2014-06-25 | -$1.55M 10-Q · filed 2012-11-09 | -$3.09M 10-Q · filed 2013-11-18 | -$3.10M derived: sum of 3 quarters · filed 2014-06-25 | -$3.10M derived: sum of 4 quarters · filed 2014-06-25 | |||
| 2012-06-30 | -$1.54M 10-K · filed 2014-06-25 | -$1.54M 10-Q · filed 2012-08-14 | -$1.54M derived: sum of 2 quarters · filed 2014-06-25 | -$1.54M derived: sum of 3 quarters · filed 2014-06-25 | -$1.55M derived: sum of 4 quarters · filed 2014-06-25 | |||
| 2012-03-31 | -$1.47K 10-K · filed 2013-06-25 | -$3.53K derived: sum of 2 quarters · filed 2013-06-25 | -$5.47K derived: sum of 3 quarters · filed 2013-06-25 | -$7.43M 10-K · filed 2013-06-25 | ||||
| 2011-12-31 | -$2.06K 10-K · filed 2013-06-25 | -$2.06M 10-Q · filed 2012-02-21 | -$4.00K derived: sum of 2 quarters · filed 2013-06-25 | -$5.96M 10-Q · filed 2013-02-14 | -$1.47M derived: sum of 4 quarters · filed 2013-06-25 | |||
| 2011-09-30 | -$1.94K 10-K · filed 2013-06-25 | -$1.94M 10-Q · filed 2011-11-14 | -$3.90M 10-Q · filed 2012-11-09 | -$1.47M derived: sum of 3 quarters · filed 2013-06-25 | -$2.81M derived: sum of 4 quarters · filed 2013-06-25 | |||
| 2011-06-30 | -$1.96K 10-K · filed 2013-06-25 | -$1.96M 10-Q · filed 2011-08-15 | -$1.47M derived: sum of 2 quarters · filed 2013-06-25 | -$2.81M derived: sum of 3 quarters · filed 2013-06-25 | -$4.29M derived: sum of 4 quarters · filed 2013-06-25 | |||
| 2011-03-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27 | -$2.81M derived: sum of 2 quarters · filed 2012-06-27 | -$4.29M derived: sum of 3 quarters · filed 2012-06-27 | -$5.60M 10-K · filed 2012-06-27 | ||||
| 2010-12-31 | -$1.34M 10-Q · filed 2012-02-21 | -$2.83M derived: sum of 2 quarters · filed 2012-02-21 | -$4.13M 10-Q · filed 2012-02-21 | |||||
| 2010-09-30 | -$1.48M 10-Q · filed 2011-11-14 | -$2.79M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$1.31M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |